HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Metergoline in the management of hyperprolactinemic amenorrhea and anovulation.

Abstract
84 patients with elevated serum PRL levels, ranging from 25 to 253 ng/ml, were treated with an antiserotonin agent, metergoline, at the dose of 12 mg/day for 90 days. The clinical complaint was of amenorrhea in 70 cases (plus galactorrhea in 44 cases) and of anovulation in 14 cases (plus galactorrhea in 6 cases). Hyperprolactinemia was due to a pituitary adenoma in 18 cases; in 53 cases it was of unknown origin, while in 7 cases it followed treatment with neuroleptics or with oral contraceptives and in 6 cases it followed a puerperium. In patients with amenorrhea, metergoline induced the appearance of menses in 61 cases (94%), and of ovulation in 46 cases (82%). In 13 of the 14 patients with anovulation, ovulation was restored. Galactorrhea disappeared in 40 out of 50 patients. Metergoline normalized serum PRL levels (less than 20 ng/ml) in 46 cases and significantly reduced serum PRL levels in all but 3 of the remaining patients. In spite of suggested nonhormonal contraceptive measures, 14 patients became pregnant; 2 had abortions and the remaining 12 patients completed by vaginal delivery, uneventful pregnancies. These results indicate metergoline as a safe and effective drug in the management of hyperprolactinemic amenorrhea and anovulation. 49 patients were followed for 2 additional months, receiving no treatment (24 cases) or metergoline at a reduced daily dosage (8 mg/day, 25 cases). Within 60 days, 60% of the first group had relapse of the clinical condition and a rebound elevation of serum PRL levels while only 20% of the second group experienced relapse of amenorrhea and rebound elevation of serum PRL levels (p less than 0.01).
AuthorsL Falsetti, A M Voltolini, P G Crosignani, G Lotti, P Travaglini, G Faglia, A Cianci, G Palumbo, C Praga, A E Pontiroli
JournalGynecologic and obstetric investigation (Gynecol Obstet Invest) Vol. 13 Issue 2 Pg. 108-16 ( 1982) ISSN: 0378-7346 [Print] Switzerland
PMID7035305 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • Ergolines
  • Metergoline
  • Prolactin
Topics
  • Amenorrhea (drug therapy, etiology)
  • Anovulation (drug therapy, etiology)
  • Clinical Trials as Topic
  • Ergolines (therapeutic use)
  • Female
  • Galactorrhea (drug therapy)
  • Humans
  • Metergoline (therapeutic use)
  • Pregnancy
  • Prolactin (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: